You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)

Article metrics

Article menu

Download PDFPDF

Psoriatic arthritis
Original article
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)

 

Online download statistics by month:

Online download statistics by month: February 2018 to September 2024

AbstractFullPdf
Feb 201814714863
Mar 201811912159
Apr 2018575835
May 2018848630
Jun 201812212335
Jul 2018828229
Aug 201813713859
Sep 2018626225
Oct 201811811848
Nov 201810410446
Dec 201810210235
Jan 201915515556
Feb 201916916955
Mar 201915715565
Apr 201912312247
May 2019888843
Jun 201910210243
Jul 2019727326
Aug 2019777631
Sep 2019818125
Oct 201910410538
Nov 2019777528
Dec 2019797927
Jan 2020555421
Feb 2020404018
Mar 2020626227
Apr 202038386
May 2020282812
Jun 2020313113
Jul 2020353312
Aug 202027268
Sep 2020403812
Oct 202042389
Nov 202032298
Dec 2020302611
Jan 202127278
Feb 202129265
Mar 202125228
Apr 2021393913
May 202124248
Jun 202127263
Jul 2021282611
Aug 2021191610
Sep 2021201918
Oct 2021292615
Nov 2021131319
Dec 202123228
Jan 202216164
Feb 202213135
Mar 202224225
Apr 202223205
May 2022343213
Jun 2022282810
Jul 202215155
Aug 202233324
Sep 2022312910
Oct 202223233
Nov 2022182017
Dec 2022141420
Jan 202359584
Feb 202338362
Mar 202316134
Apr 202315155
May 2023161512
Jun 202310101
Jul 2023161415
Aug 202313134
Sep 202310104
Oct 202316161
Nov 202332314
Dec 202320202
Jan 202413135
Feb 202421208
Mar 202425244
Apr 202421217
May 202431314
Jun 2024383610
Jul 2024353411
Aug 202413123
Sep 202416155
Total392738721447